This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Strategies for Treatment of Generalized Anxiety in the Primary Care Setting

Edward Schweizer, M.D., and Karl Rickels, M.D.

Published: April 1, 1997

Article Abstract

Generalized Anxiety Disorder (GAD) is a highly prevalent condition whose course of illness isoften chronic in nature and fluctuating in severity. Pharmacotherapy options include the benzodiazepines,the azapirones, of which only buspirone is marketed at the present time, and the antidepressantimipramine. Buspirone is probably the treatment of choice when prolonged therapy is indicated becauseit does not produce physical dependence, dose not interact with alcohol, and does not cause psychomotorimpairment. Dosing instructions for buspirone and guidelines for switching patients frombenzodiazepines to buspirone are offered. Non-drug therapies such as interpersonal and cognitivetherapies are often also found helpful in treating patients with GAD.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 58

Quick Links: Anxiety , Anxiolytics

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...